Johannes T. Cramer

Johannes T. Cramer

Auto-generated profile, based on publicly available information

Johannes T. Cramer

Institute of Virology, Hannover Medical School, 30625 Hannover, Germany

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2020 in Science
Verified
Journal Article
Closed access
PDF file
FSFabian Sesterhenn
Fabian Sesterhenn
CYChe Yang
Che Yang
JBJaume Bonet
Jaume Bonet
JCJohannes T. Cramer
Johannes T. Cramer
XWXiaolin Wen
Xiaolin Wen
BCBruno E. Correia
Bruno E. Correia
TopoBuilding precision vaccines: To induce strong and targeted neutralizing antibody (nAb) responses against vaccine targets, one strategy has been to use computationally designed immunogens. However, the structural complexity of many known neutralization epitopes has posed a major challenge for the design of accurate epitope mimetics. Sesterhenn et al. created a protein design algorithm called TopoBuilder to design scaffolds for irregular and discontinuous neutralization epitopes. As a proof of principle, the authors generated epitope-focused immunogens based on the prefusion conformation of the respiratory syncytial virus (RSV) fusion protein. When these immunogens were used to vaccinate mice and nonhuman primates in RSV infection models, they generated targeted nAb responses to RSV and boosted site-specific nAb responses in heterologous prime-boost vaccination schemes. Science , this issue p. eaay5051

4 January 2021 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
CYChe Yang
Che Yang
FSFabian Sesterhenn
Fabian Sesterhenn
JBJaume Bonet
Jaume Bonet
EAEva A. van Aalen
Eva A. van Aalen
LSLeo Scheller
Leo Scheller
BCBruno E. Correia
Bruno E. Correia

18 September 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
TFTimm Fiebig
Timm Fiebig
JCJohannes T. Cramer
Johannes T. Cramer
ABAndrea Bethe
Andrea Bethe
PBPetra Baruch
Petra Baruch
UCUte Curth
Ute Curth
MMMartina Mühlenhoff
Martina Mühlenhoff
O-Acetylation of the capsular polysaccharide (CPS) of Neisseria meningitidis serogroup A (NmA) is critical for the induction of functional immune responses, making this modification mandatory for CPS-based anti-NmA vaccines. Using comprehensive NMR studies, we demonstrate that O-acetylation stabilizes the labile anomeric phosphodiester-linkages of the NmA-CPS and occurs in position C3 and C4 of the N-acetylmannosamine units due to enzymatic transfer and non-enzymatic ester migration, respectively. To shed light on the enzymatic transfer mechanism, we solved the crystal structure of the capsule O-acetyltransferase CsaC in its apo and acceptor-bound form and of the CsaC-H228A mutant as trapped acetyl-enzyme adduct in complex with CoA. Together with the results of a comprehensive mutagenesis study, the reported structures explain the strict regioselectivity of CsaC and provide insight into the catalytic mechanism, which relies on an unexpected Gln-extension of a classical Ser-His-Asp triad, embedded in an α/β-hydrolase fold.

6 December 2024 in Science Advances
Verified
Journal Article
Open access
KNKumar Nagarathinam
Kumar Nagarathinam
ASAndreas Scheck
Andreas Scheck
MLMaurice Labuhn
Maurice Labuhn
LSLuisa J. Ströh
Luisa J. Ströh
EHElisabeth Herold
Elisabeth Herold
TKThomas Krey
Thomas Krey
Hepatitis C virus (HCV) infection causes ~290,000 annual human deaths despite the highly effective antiviral treatment available. Several viral immune evasion mechanisms have hampered the development of an effective vaccine against HCV, among them the remarkable conformational flexibility within neutralization epitopes in the HCV antigens. Here, we report the design of epitope-focused immunogens displaying two distinct HCV cross-neutralization epitopes. We show that these immunogens induce a pronounced, broadly neutralizing antibody response in laboratory and transgenic human antibody mice. Monoclonal human antibodies isolated from immunized human antibody mice specifically recognized the grafted epitopes and neutralized four diverse HCV strains. Our results highlight a promising strategy for developing HCV immunogens and provide an encouraging paradigm for targeting structurally flexible epitopes to improve the induction of neutralizing antibodies.